5SP-17749-46756

3 vaccinations 12 coded responses 28 check-ins 12 free-text entries 13 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 222 / VA
Registered: 2020-12-20

Relationship: Self
Race: Multiracial
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Registered in v-safe
2020-12-20
Dose 1 — Pfizer-BioNTech
2020-12-20
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Nausea · Be unable to do your normal daily activities

Adult check-in
2020-12-20
Report sent to call center — day 0, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-21
Survey response — days 1–6 daily, dose 1
MedDRA: Rash — Feeling: Fair · Site: Pain, Redness · Diarrhea

Free text: Developed rash on opposite side of arm (same arm of injection site) 6 hours after

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Survey response — days 1–6 daily, dose 1
MedDRA: Abdominal distension — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Abdominal distention/bloating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2020-12-23
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · Joint pains

Adult check-in
2020-12-27
Health check-in — day 7, dose 1
Feeling: Good · Fever · Headache

Adult check-in
2021-01-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-10
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-12
Report sent to call center — day 0, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Survey response — days 1–6 daily, dose 2
MedDRA: Autoimmune disorder, Chills, Condition aggravated, Hyperhidrosis, Insomnia, Neck pain, Pre-existing disease, Sleep disorder — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Rigors (woke me up from sound sleep), profusely sweating (woke me up from sound sleep), briefly pain in my neck, increased flaring of autoimmune disorder (connective tissue disorder)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Pruritus — Feeling: Good · Site: Pain, Swelling, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Itching on neck and arms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling hot, Hyperhidrosis, Menstrual disorder — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Increased periods of feeling warm/sweating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling hot — Feeling: Fair · Site: Swelling · Fever · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Periods of feeling warm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-19
Health check-in — day 7, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Survey response — day 42, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: Increased symptoms of autoimmune disorder (polychondritis vs. undifferentiated connective tissue disorder) including pain in skin, joints, ear, nose, and increased fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Survey response — 3 months, dose 2
MedDRA: Eczema — Feeling: Good

Free text: Eczema on both upper arms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Survey response — 6 months, dose 2
MedDRA: Blood pressure decreased, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Symptoms: Significant drop in blood pressure of unknown etiology (requiring use of vasopressor prescription); under the care of cardiologist · Healthcare visit (other): In-person office visits

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-14
Call 1 — Left Voicemail
2021-07-15
Call successful
Participant prefers to complete VAERS report online
2021-10-19
Dose 3 — Pfizer-BioNTech
2022-01-12
Survey response — 12 months, dose 2
MedDRA: Heart rate increased, Hypotension — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Persistent low blood pressure (since May 2021), requiring Midodrine 3x/day Increased heart rate (noted this past December 2021) · Healthcare visit (other): Will be following up with outpatient cardiologist next week for low blood pressure

MedDRA releases: 2024-11 · check-in free text available
2022-01-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-13
Call 1 — Left Voicemail
2022-04-20
Survey response — 6 months, dose 3
MedDRA: COVID-19, Office visit, Postural orthostatic tachycardia syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Diagnosed with POTS in 1/2022 by cardiologist. Diagnosed with COVID 4/12/22.

MedDRA releases: 2024-11 · check-in free text available
2022-04-20
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-21
Call successful
Participant prefers to complete VAERS report online
2022-10-21
Survey response — 12 months, dose 3
MedDRA: Autonomic nervous system imbalance, Postural orthostatic tachycardia syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Diagnosed with suspected Autonomic Dysfunction and POTS

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-10-24
Call 1 — Left Voicemail
2022-10-24
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-10-19	Pfizer-BioNTech	No

Call center

13 call center cases

4 successful · 9 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-21

Systemic reaction (other): Developed rash on opposite side of arm (same arm of injection site) 6 hours after

2020-12-22

Systemic reaction (other): Abdominal distention/bloating

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Rigors (woke me up from sound sleep), profusely sweating (woke me up from sound sleep), briefly pain in my neck, increased flaring of autoimmune disorder (connective tissue disorder)

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): Itching on neck and arms

2021-01-17

Systemic reaction (other): Increased periods of feeling warm/sweating

2021-01-18

Systemic reaction (other): Periods of feeling warm

Release 4 — day 42, dose 2

2021-02-23

Symptoms: Increased symptoms of autoimmune disorder (polychondritis vs. undifferentiated connective tissue disorder) including pain in skin, joints, ear, nose, and increased fatigue

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: Eczema on both upper arms

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Significant drop in blood pressure of unknown etiology (requiring use of vasopressor prescription); under the care of cardiologist

Healthcare visit (other): In-person office visits

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: Persistent low blood pressure (since May 2021), requiring Midodrine 3x/day Increased heart rate (noted this past December 2021)

Healthcare visit (other): Will be following up with outpatient cardiologist next week for low blood pressure

Release 11 — 6 months, dose 3

2022-04-20

Symptoms: Diagnosed with POTS in 1/2022 by cardiologist. Diagnosed with COVID 4/12/22.

Release 12 — 12 months, dose 3

2022-10-21

Symptoms: Diagnosed with suspected Autonomic Dysfunction and POTS

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Hypotension	·	·	✓
HCVO	Office visit	✓	✓	✓
SD	Autonomic nervous system imbalance	·	·	✓
SD	Blood pressure decreased	✓	✓	✓
SD	Condition aggravated	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Eczema	✓	✓	✓
SD	Heart rate increased	·	·	✓
SD	Hospitalisation	○	○	○
SD	Hypertension	○	○	○
SD	Hypotension	·	·	✓
SD	Office visit	·	·	✓
SD	Postural orthostatic tachycardia syndrome	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Abdominal distension	✓	✓	✓
SRO	Autoimmune disorder	○	✓	○
SRO	Chills	✓	✓	✓
SRO	Condition aggravated	✓	·	✓
SRO	Feeling hot	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓
SRO	Insomnia	○	✓	○
SRO	Menstrual disorder	✓	✓	✓
SRO	Neck pain	✓	✓	✓
SRO	Pre-existing disease	✓	·	✓
SRO	Pruritus	✓	✓	✓
SRO	Rash	✓	✓	✓
SRO	Sleep disorder	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release